Grifols (GIKLY) Exchange Rate Effect (2009 - 2021)
Grifols (GIKLY) posted Exchange Rate Effect of $15.1 million for Q1 2020, down 73.68% quarter-over-quarter from $57.4 million in Q4 2019, and down 32.13% year-on-year from $22.3 million in Q2 2019.
Grifols (GIKLY) Exchange Rate Effect (2009 - 2021) Analysis & Trends
Grifols (GIKLY) has reported Exchange Rate Effect for 11 consecutive years, with $15.1 million the latest figure, recorded in Q1 2020.
- Exchange Rate Effect for Q1 2020 came in at $15.1 million, down 32.13% year-over-year; the trailing twelve-month figure through Mar 2020 was $128.3 million (up 273.28% YoY), and the FY2025 annual result was -$109.4 million, down 565.44% from the prior year.
- Exchange Rate Effect was $15.1 million for Q1 2020 at Grifols, down from $57.4 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $515.7 million in Q3 2016 and troughed at -$102.1 million in Q4 2017.
- Average Exchange Rate Effect over 5 years is $59.4 million, with a median of $18.7 million recorded in 2020.
- The widest YoY moves for Exchange Rate Effect: up 432.43% in 2018, down 344.96% in 2018.
- Over 5 years, Exchange Rate Effect stood at $66.1 million in 2016, then tumbled by 254.32% to -$102.1 million in 2017, then jumped by 132.8% to $33.5 million in 2018, then surged by 71.52% to $57.4 million in 2019, then plunged by 73.68% to $15.1 million in 2020.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $15.1 million in Q1 2020, $57.4 million in Q4 2019, and $22.3 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 67.00 Mn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | -25.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -12.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -18.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -19.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | -11.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 19.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -77.00 Mn |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 382.83 Mn |
| Dec 31, 2021 | 382.83 Mn |
| Dec 31, 2020 | -324.93 Mn |
| Dec 31, 2020 | -324.93 Mn |
| Mar 31, 2020 | 15.12 Mn |
| Mar 31, 2020 | 15.12 Mn |
| Dec 31, 2019 | 57.43 Mn |
| Dec 31, 2019 | 57.43 Mn |
| Mar 31, 2019 | 22.27 Mn |
| Mar 31, 2019 | 22.27 Mn |
| Dec 31, 2018 | 33.48 Mn |
| Dec 31, 2018 | 33.48 Mn |
| Jun 30, 2018 | 264.72 Mn |
| Jun 30, 2018 | 264.72 Mn |
| Mar 31, 2018 | -27.72 Mn |
| Mar 31, 2018 | -27.72 Mn |
| Dec 31, 2017 | -102.07 Mn |
| Dec 31, 2017 | -102.07 Mn |
| Jun 30, 2017 | -79.63 Mn |
| Jun 30, 2017 | -79.63 Mn |